跳至主要内容
临床试验/2024-514602-31-00
2024-514602-31-00已完成3 期

Long-term aspirin therapy as a predictor of decreased susceptibility to SARSCoV-2 infection in aspirin-exacerbated respiratory disease

Uniwersytet Jagiellonski Collegium Medicum, Uniwersytet Jagiellonski Collegium Medicum1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2024年7月1日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
76
试验地点
1
主要终点
whether aspirin desensitization followed by long-term high-dose aspirin therapy in patients with AERD associated with lower gene expression of ACE2, TMPRSS2, BSG, PPIA, PPIB, DPP4, IFNA1, IFNB1 IFNG, IFNL1 i IFNL2 and ISG in sputum and nasal cells.

研究概览

简要总结

to determine whether treatment with aspirin, which inhibits cyclooxygenase-1 enzyme, can serve as a predictor of decreased susceptibility to SARS-CoV-2 infection and COVID-19 in patients with AERD. 2. to assess genetic features that might predict or attenuate SARS-CoV-2 infection on high-dose aspirin therapy.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • INCLUSION CRITERIA FOR AERD PATIENTS:* signed informed consent form * 18-70 years old AERD patients with baseline FEV1 of at least 70% of the predicted value on the challenge/desensitization day * no pregnancy, higly effective contraception must be used
  • INCLUSION CRITERIA FOR HEALTHY CONTROL: * signed informed consent form * 18-70 years old and healthy condition * no asthma

排除标准

  • failure of the circulatory and respiratory system, liver, kidneys and other vital organs
  • diabetes, cancer, systemic diseases of connective tissue, infectious diseases, coagulation disorders, active peptic ulcer disease, any active bleeding process.
  • Use of drugs that interact with aspirin
  • use of intoxicants, alcohol abuse, active and passive smoking
  • pregnancy, lactation
  • hypersensitivity to the active substance or any of the excipients

结局指标

主要结局

whether aspirin desensitization followed by long-term high-dose aspirin therapy in patients with AERD associated with lower gene expression of ACE2, TMPRSS2, BSG, PPIA, PPIB, DPP4, IFNA1, IFNB1 IFNG, IFNL1 i IFNL2 and ISG in sputum and nasal cells.

whether aspirin desensitization followed by long-term high-dose aspirin therapy in patients with AERD associated with lower gene expression of ACE2, TMPRSS2, BSG, PPIA, PPIB, DPP4, IFNA1, IFNB1 IFNG, IFNL1 i IFNL2 and ISG in sputum and nasal cells.

次要结局

  • Whether the change of gene expression during aspirin therapy is connected with lower risk of SARS-CoV-2 infection

研究者

发起方
Uniwersytet Jagiellonski Collegium Medicum, Uniwersytet Jagiellonski Collegium Medicum
申办方类型
Educational Institution, Educational Institution
责任方
Principal Investigator
主要研究者

Prof. Lucyna Mastalerz

Scientific

Uniwersytet Jagiellonski Collegium Medicum

研究点 (1)

Loading locations...

相似试验